Technologies Transferred and/or Commercialized

Natural Streptokinase

Transferred to M/S Cadila Pharma. Ltd., Ahmedabad in 2001

Recombinant Streptokinase

Transferred to M/S Shasun Chemicals & Drugs Ltd., Chennai in 2002-03; Launched for Indian markets in July 10, 2009 under different brand names

Clot-Specific Streptokinase

Transferred to Nostrum Pharmaceuticals Inc., USA in 2006; Work on upscaling and human testing (Phase-I) is completed successfully and Phase-II has been approved

Anti thrombotic clot busters with optimised half-life

Transferred to Nostrum Pharmaceuticals Inc., USA in 2010

Immunosuppressive Agent - Caerulomycin A

Licensed to Nostrum Pharmaceuticals Inc., USA

Energy Efficient Alcohol Technology

Transfer of technology to McDowell & Company

Development Of A Live, Oral, Recombinant Vaccine For Cholera

Recombinant Staphylokinase

Transferred to M/s Strides Arcolab Ltd., Bangalore

Vaxipred- A Software Tool For Vaccine Design

licensed to National Institute for Biologicals, Noida